Neuropeptide Y gene polymorphism and plasma neuropeptide Y level in febrile seizure patients in Taiwan

Kaohsiung Journal of Medical Sciences

Volumn 23, Issue 11, 2007, Pages 560-565

  Lin, Lung Chang ^a   Lin, Hung Shun ^a   Yang, Rei Cheng ^b,c  

^a KAOHSIUNG MUNICIPAL HSIAO KANG HOSPITAL   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Febrile seizures; Neuropeptide Y; Polymorphism

Indexed keywords

GENOMIC DNA; NEUROPEPTIDE Y;

ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DNA EXTRACTION; DNA POLYMORPHISM; EPILEPSY; FEBRILE CONVULSION; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; NERVE CELL EXCITABILITY; TAIWAN;

EID: 37149042571     PISSN: 1607551X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1607-551X(08)70003-2     Document Type: Article

References (21)

1. Kaplan RE. Febrile seizures. When is treatment justified? Postgrad Med 1987;82:63-6,69-71.
2. De Quidt ME, Emson PC. Distribution of neuropeptide Y-like immunoreactivity in the rat central nervous system: II. Immunohistochemical analysis. Neuroscience 1986;18:545-618.
3. Woldbye DP, Larsen PJ, Mikkelsen JD, et al. Powerful inhibition of kainic acid seizures by neuropeptide Y via Y5-like receptors. Nat Med 1997;3:761-4.
4. Dube C, Brunson KL, Eghbal-Ahmadi M, et al. Endogenous neuropeptide Y prevents recurrence of experimental febrile seizures by increasing seizure threshold. J Mol Neurosci 2005;25:275-83.
5. Marsh DJ, Baraban SC, Hollopeter G, et al. Role of the Y5 neuropeptide Y receptor in limbic seizures. Proc Natl Acad Sci USA 1999;96:13518-23.
6. Baraban SC, Hollopeter G, Erickson JC, et al. Knock-out mice reveal a critical antiepileptic role for neuropeptide Y. J Neurosci 1997;17:8927-36.
7. Erickson JC, Klegg KE, Palmiter RD. Sensitivity to leptin and susceptibility to seizures of mice lacking neuropeptide Y. Nature 1996;381:415-21.
8. Okubo T, Harada S. Polymorphism of the neuropeptide Y gene: an association study with alcohol withdrawal. Alcohol Clin Exp Res 2001;25:59S-62S.
9. Freeman JM. Consensus statement - febrile seizure: a consensus of their significance, evaluation, and treatment. Pediatrics 1980;66:1009-12.
10. Chou IC, Peng CT, Tsai FJ, et al. The lack of association between febrile convulsions and polymorphisms in SCN1A. Epilepsy Res 2003;54:53-7.
11. Chou IC, Tsai CH, Lee CC, et al. Brain-derived neurotrophic factor (BDNF) Val66Met polymorphisms in febrile seizures. Epilepsy Res 2004;60:27-9.
12. Tsai FJ, Chou IC, Hsieh YY, et al. Interleukin-4 intron 3 polymorphism is not related to susceptibility to febrile seizures. Pediatr Neurol 2002;27;271-4.
13. Chou IC, Lee CC, Huang CC, et al. Association of the neuronal nicotinic acetylcholine receptor subunit α4 polymorphisms with febrile convulsions. Epilepsia 2003;44:1089-93.
14. Peng CT, Chou IC, Li CI, et al. Association of the nicotinic receptor beta 2 subunit and febrile seizures. Pediatr Neurol 2004;30:186-9.
15. Chou IC, Tsai FJ, Huang CC, et al. The voltage-gated potassium channel KCNQ2 in Taiwanese children with febrile convulsions. Neuroreport 2002;13:1971-3.
16. Vizzani A, Sperk G, Colmers WF. Neuropeptide Y: emerging evidence for a functional role in seizure modulation. Trends Neurosci 1999;22:25-30.
17. Patrylo PR, van den Pol AN, Spencer DD, et al. NPY inhibits glutamatergic excitation in the epileptic human dentate gyrus. J Neurophysiol 1999;82:478-83.
18. Reibel S, Nadi S, Benmaamar R, et al. Neuropeptide Y and epilepsy: varying effects according to seizure type and receptor activation. Peptide 2001;22:529-39.
19. Lin S, Boey D, Herzog H. NPY and Y receptors: lessons from transgenic and knockout models. Neuropeptides 2004;38:189-200.
20. Furtinger S, Pirker S, Czech T, et al. Plasticity of Y1 and Y2 receptors and neuropeptide Y fibers in patients with temporal lobe epilepsy. J Neurosci 2001;21:5804-12.
21. Higuchi H, Yokokawa K, Iwasa A, et al. Age-dependent increase in neuropeptide Y gene expression in rat adrenal gland and specific brain areas. J Neurochem 1991;57:1840-47.